Cargando…
HPV E6, E6AP and cervical cancer
Every year, approximately 470,000 new cases of cervical cancer are diagnosed and approximately 230,000 women worldwide die of the disease, with the majority (~80%) of these cases and deaths occurring in developing countries. Human papillomaviruses (HPVs) are the etiological agents in nearly all case...
Autores principales: | Beaudenon, Sylvie, Huibregtse, Jon M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582798/ https://www.ncbi.nlm.nih.gov/pubmed/19007434 http://dx.doi.org/10.1186/1471-2091-9-S1-S4 |
Ejemplares similares
-
Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation
por: Li, Siying, et al.
Publicado: (2019) -
Hepatitis C Virus Induces E6AP-Dependent Degradation of the Retinoblastoma Protein
por: Munakata, Tsubasa, et al.
Publicado: (2007) -
The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6
por: Zanier, Katia, et al.
Publicado: (2014) -
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
por: Martinez-Zapien, Denise, et al.
Publicado: (2016) -
Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins
por: Gutiérrez-Hoya, Adriana, et al.
Publicado: (2020)